Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Pulmonology

Pulm/Thoracic Infections

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): A randomized, controlled, open-label, platform trial

The Lancet | Feb 15, 2022 Pulm/Thoracic Infections

History of bariatric surgery and COVID‐19 outcomes in patients with type 2 diabetes: Coronado study

Obesity | Feb 15, 2022 Pulm/Thoracic Infections

Delayed cardiac repolarization as a predictor of in-hospital mortality in patients with COVID-19

Heart | Feb 15, 2022 Pulm/Thoracic Infections

Lonely older adults are more likely to delay or avoid medical care during the COVID-19 pandemic (11/7/21)

International Journal of Geriatric Psychiatry | Feb 15, 2022 Pulm/Thoracic Infections

Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19

JAMA | Feb 11, 2022 Pulm/Thoracic Infections

Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: The RECOVERY-RS randomized clinical trial

JAMA | Feb 11, 2022 Pulm/Thoracic Infections

Efficacy and safety of COVID-19 convalescent plasma in hospitalized patients: A randomized clinical trial

JAMA | Feb 10, 2022 Pulm/Thoracic Infections

Risk of infection, hospitalization, and death up to 9 months after a second dose of COVID-19 vaccine: A retrospective, total population cohort study in Sweden

The Lancet | Feb 09, 2022 Pulm/Thoracic Infections

Hyperimmune immunoglobulin for hospitalized patients with COVID-19 (ITAC): A double-blind, placebo-controlled, phase 3, randomized trial

The Lancet | Feb 08, 2022 Pulm/Thoracic Infections

Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink

PLoS Medicine | Feb 04, 2022 Pulm/Thoracic Infections

« Prev 1 2 3 4 5 … 93 Next »

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): A randomized, controlled, open-label, platform trial

History of bariatric surgery and COVID‐19 outcomes in patients with type 2 diabetes: Coronado study

Delayed cardiac repolarization as a predictor of in-hospital mortality in patients with COVID-19

Lonely older adults are more likely to delay or avoid medical care during the COVID-19 pandemic (11/7/21)

Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19

Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: The RECOVERY-RS randomized clinical trial

Efficacy and safety of COVID-19 convalescent plasma in hospitalized patients: A randomized clinical trial

Risk of infection, hospitalization, and death up to 9 months after a second dose of COVID-19 vaccine: A retrospective, total population cohort study in Sweden

Hyperimmune immunoglobulin for hospitalized patients with COVID-19 (ITAC): A double-blind, placebo-controlled, phase 3, randomized trial

Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): A randomized, controlled, open-label, platform trial

History of bariatric surgery and COVID‐19 outcomes in patients with type 2 diabetes: Coronado study

Delayed cardiac repolarization as a predictor of in-hospital mortality in patients with COVID-19

Lonely older adults are more likely to delay or avoid medical care during the COVID-19 pandemic (11/7/21)

Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19

Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: The RECOVERY-RS randomized clinical trial

Efficacy and safety of COVID-19 convalescent plasma in hospitalized patients: A randomized clinical trial

Risk of infection, hospitalization, and death up to 9 months after a second dose of COVID-19 vaccine: A retrospective, total population cohort study in Sweden

Hyperimmune immunoglobulin for hospitalized patients with COVID-19 (ITAC): A double-blind, placebo-controlled, phase 3, randomized trial

Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Select Specialty

Select Topic